Literature DB >> 29982970

Letter to the Editor regarding the article "The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions".

Michael Dandel1,2, Gerd Wallukat3, Roland Hetzer4,5.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29982970     DOI: 10.1007/s10741-018-9725-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  7 in total

1.  Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Authors:  Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2013-07       Impact factor: 2.821

2.  Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.

Authors:  Michael Dandel; Angela Englert; Gerd Wallukat; Andrea Riese; Christoph Knosalla; Julia Stein; Roland Hetzer
Journal:  Atheroscler Suppl       Date:  2015-05       Impact factor: 3.235

3.  Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors.

Authors:  P Hempel; P Karczewski; K-D Kohnert; J Raabe; B Lemke; R Kunze; M Bimmler
Journal:  Scand J Immunol       Date:  2009-08       Impact factor: 3.487

4.  [Positive rate of autoantibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension].

Authors:  Lin-Shuang Zhao; Yu-Hua Liao; Guang-da Xiang; Min Wang; Ling Yue; Zi-Hua Zhou; Hui-Ling Sun
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2010-02

5.  Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.

Authors:  Michael Dandel; Gerd Wallukat; Angela Englert; Hans B Lehmkuhl; Christoph Knosalla; Roland Hetzer
Journal:  Eur J Heart Fail       Date:  2012-08-14       Impact factor: 15.534

6.  Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.

Authors:  Linshuang Zhao; Chunyan Xu; Jinling Xu
Journal:  Cardiology       Date:  2014-10-11       Impact factor: 1.869

Review 7.  The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.

Authors:  Anne Pernille Ofstad; Dan Atar; Lars Gullestad; Gisle Langslet; Odd Erik Johansen
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.